SCHEMBL11904037

SCHEMBL11904037

CCOC(=O)CCCCCn1cc(C(=O)c2cccc3ccccc23)c2ccccc21

nearest known ligand 0.98

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 4/20 0.98
CNR2 P34972 9/20 0.72
CREBBP Q92793 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17025795 0.99 CNR1 (1.00) CNR1CNR2CREBBP
SCHEMBL17025784 0.96 CNR1 (1.00) CNR1CNR2CREBBP
SCHEMBL15587805 0.88 CNR1 (0.81) CNR1CNR2
SCHEMBL11984943 0.86 CNR2 (0.77) CNR1CNR2
SCHEMBL16201691 0.86 CNR2 (0.98) CNR1CNR2
SCHEMBL29362566 0.86 CNR2 (0.98) CNR1CNR2
SCHEMBL29988966 0.86 CNR2 (0.98) CNR1CNR2
SCHEMBL16201689 0.86 CNR2 (0.98) CNR1CNR2
SCHEMBL11903696 0.85 CNR2 (0.74) CNR1CNR2
SCHEMBL29361900 0.84 CNR2 (1.00) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10175258-B2 Detection of synthetic cannabinoids RANDOX LABORATORIES LIMITED (GB) 2019-01-08 US disclosed
US-10175258-B2 Detection of synthetic cannabinoids RANDOX LABORATORIES LIMITED (GB) 2019-01-08 US disclosed
US-9434687-B2 Detection of synthetic cannabinoids RANDOX LABORATORIES LIMITED (GB) 2016-09-06 US disclosed
US-20150118763-A1 DETECTION OF SYNTHETIC CANNABINOIDS RANDOX LABORATORIES LIMITED (GB) 2015-04-30 US disclosed
US-20150118763-A1 DETECTION OF SYNTHETIC CANNABINOIDS RANDOX LABORATORIES LIMITED (GB) 2015-04-30 US disclosed
EP-2487155-B1 Detection of Synthetic Cannabinoids RANDOX LAB LTD (GB) 2015-01-21 EP disclosed
US-8906633-B2 Detection of synthetic cannabinoids RANDOX LABORATORIES LIMITED (GB) 2014-12-09 US disclosed
US-8906633-B2 Detection of synthetic cannabinoids RANDOX LABORATORIES LIMITED (GB) 2014-12-09 US disclosed
EP-2698385-A1 Detection of synthetic cannabinoids Randox Laboratories Ltd. (GB) 2014-02-19 EP disclosed
US-20130066053-A1 Detection of Synthetic Cannabinoids RANDOX LABORATORIES LIMITED (GB) 2013-03-14 US disclosed
US-20120208213-A1 Detection of Synthetic Cannabinoids RANDOX LABORATORIES LIMITED (GB) 2012-08-16 US disclosed
US-20120208213-A1 Detection of Synthetic Cannabinoids RANDOX LABORATORIES LIMITED (GB) 2012-08-16 US disclosed
EP-2487155-A1 Detection of Synthetic Cannabinoids Randox Laboratories Ltd. (GB) 2012-08-15 EP disclosed
EP-2487155-A1 Detection of Synthetic Cannabinoids Randox Laboratories Ltd. (GB) 2012-08-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150118763-A1 DETECTION OF SYNTHETIC CANNABINOIDS CNR2, CNR1, FAAH CNR1 2/4885CNR2 1/4885CREBBP 869/4885
US-20130066053-A1 Detection of Synthetic Cannabinoids CNR2, CNR1, FAAH CNR1 2/4885CNR2 1/4885CREBBP 869/4885
US-20120208213-A1 Detection of Synthetic Cannabinoids CNR2, CNR1, FAAH CNR1 2/4885CNR2 1/4885CREBBP 869/4885
US-10175258-B2 Detection of synthetic cannabinoids CNR2, CNR1, FAAH CNR1 2/4885CNR2 1/4885CREBBP 869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.